Praxis Precision Medicines to Present at 2022 Wedbush PacGrow Healthcare Conference

Rhea-AI Summary

Praxis Precision Medicines (NASDAQ: PRAX) announced its participation in the Wedbush PacGrow Healthcare Virtual Conference on August 10, 2022, at 12:35 p.m. ET. The panel, titled “Got My Mind Set On You – Advancing Novel Epilepsy Targets,” will focus on therapies addressing central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance. Interested parties can access the live webcast via the company’s website, where a replay will be available for 30 days post-event. Praxis is committed to developing innovative solutions for various CNS disorders.

BOSTON, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate in the “Got My Mind Set On You – Advancing Novel Epilepsy Targets” panel at the 2022 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 10, 2022 at 12:35 p.m. ET.

The panel chat will be available via live webcast through the Events & Presentations page of the Investors + Media section of the company’s website at www.praxismedicines.com. A replay of the webcast will be available on Praxis’ website for 30 days following the event.

About Praxis
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying insights from genetic epilepsies to both rare and more prevalent neurological disorders, using our understanding of shared biological targets and circuits in the brain. Praxis has established a broad portfolio with multiple programs, including product candidates across movement disorders, epilepsy and psychiatric disorders, with three clinical-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on LinkedIn and Twitter.

FAQ

When is Praxis participating in the Wedbush PacGrow Healthcare Virtual Conference?

Praxis Precision Medicines will participate in the Wedbush PacGrow Healthcare Virtual Conference on August 10, 2022, at 12:35 p.m. ET.

What is the focus of the panel discussion at the conference?

The panel discussion is titled 'Got My Mind Set On You – Advancing Novel Epilepsy Targets' and will cover therapies for CNS disorders.

How can I access the panel webcast for Praxis?

The panel webcast can be accessed live through the Events & Presentations page on Praxis Precision Medicines' website.

Will there be a replay of the Praxis panel discussion?

Yes, a replay of the panel discussion will be available on Praxis’ website for 30 days following the event.

What does Praxis Precision Medicines focus on?

Praxis focuses on translating genetic insights into therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance.